The expression of myosin heavy chain (MHC) genes in human skeletal muscle is related to metabolic characteristics involved in the pathogenesis of type 2 diabetes

Molecular Genetics and Metabolism

Volumn 103, Issue 3, 2011, Pages 275-281

  Olsson, Anders H ^a   Rönn, Tina ^a   Elgzyri, Tarq ^a   Hansson, Ola ^a   Eriksson, Karl Fredrik ^a   Groop, Leif ^a   Vaag, Allan ^a,b   Poulsen, Pernille ^b,c   Ling, Charlotte ^a  

^a LUND UNIVERSITY   (Sweden)

^b STENO DIABETES CENTER   (Denmark)

^c Rigshospitalet   (Denmark)

Author keywords

Fibre type; Gene expression; In vivo metabolism; MHC genes

Indexed keywords

ADENOSINE TRIPHOSPHATE; INSULIN; MESSENGER RNA; MYOSIN HEAVY CHAIN; MYOSIN HEAVY CHAIN 7; MYOSIN HEAVY CHAIN II ALPHA; MYOSIN HEAVY CHAIN II X D; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA COACTIVATOR 1ALPHA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA COACTIVATOR 1BETA; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CELL COMPOSITION; ENVIRONMENTAL FACTOR; FEMALE; GENE EXPRESSION; GENETIC ANALYSIS; GENETIC PREDISPOSITION; GLUCOSE TRANSPORT; HERITABILITY; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; MUSCLE BIOPSY; MUSCLE CELL; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL; SKELETAL MUSCLE;

ADULT; AGE FACTORS; AGED; BLOOD GLUCOSE; CARRIER PROTEINS; DIABETES MELLITUS, TYPE 2; FEMALE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; HEAT-SHOCK PROTEINS; HUMANS; INSULIN; MALE; MIDDLE AGED; MUSCLE FIBERS, SKELETAL; MUSCLE, SKELETAL; MYOSIN HEAVY CHAINS; POLYMORPHISM, SINGLE NUCLEOTIDE; RNA, MESSENGER; TRANSCRIPTION FACTORS; TWINS;

EID: 79958030339     PISSN: 10967192     EISSN: 10967206     Source Type: Journal    
DOI: 10.1016/j.ymgme.2011.03.017     Document Type: Article

References (33)

1. Spangenburg E.E., Booth F.W. Molecular regulation of individual skeletal muscle fibre types. Acta Physiol. Scand. 2003, 178:413-424.
2. DeFronzo R.A., Jacot E., Jequier E., Maeder E., Wahren J., Felber J.P. The effect of insulin on the disposal of intravenous glucose. Results from indirect calorimetry and hepatic and femoral venous catheterization. Diabetes 1981, 30:1000-1007.
3. Lillioja S., Young A.A., Culter C.L., Ivy J.L., Abbott W.G., Zawadzki J.K., Yki-Jarvinen H., Christin L., Secomb T.W., Bogardus C. Skeletal muscle capillary density and fiber type are possible determinants of in vivo insulin resistance in man. J. Clin. Invest. 1987, 80:415-424.
4. Nyholm B., Qu Z., Kaal A., Pedersen S.B., Gravholt C.H., Andersen J.L., Saltin B., Schmitz O. Evidence of an increased number of type IIb muscle fibers in insulin-resistant first-degree relatives of patients with NIDDM. Diabetes 1997, 46:1822-1828.
5. Marin P., Andersson B., Krotkiewski M., Bjorntorp P. Muscle fiber composition and capillary density in women and men with NIDDM. Diabetes Care 1994, 17:382-386.
6. Tanner C.J., Barakat H.A., Dohm G.L., Pories W.J., MacDonald K.G., Cunningham P.R., Swanson M.S., Houmard J.A. Muscle fiber type is associated with obesity and weight loss. Am. J. Physiol. Endocrinol. Metab. 2002, 282:E1191-E1196.
7. Lin J., Wu H., Tarr P.T., Zhang C.Y., Wu Z., Boss O., Michael L.F., Puigserver P., Isotani E., Olson E.N., Lowell B.B., Bassel-Duby R., Spiegelman B.M. Transcriptional co-activator PGC-1 alpha drives the formation of slow-twitch muscle fibres. Nature 2002, 418:797-801.
8. Mortensen O.H., Frandsen L., Schjerling P., Nishimura E., Grunnet N. PGC-1alpha and PGC-1beta have both similar and distinct effects on myofiber switching toward an oxidative phenotype. Am. J. Physiol. Endocrinol. Metab. 2006, 291:E807-E816.
9. Ling C., Wegner L., Andersen G., Almgren P., Hansen T., Pedersen O., Groop L., Vaag A., Poulsen P. Impact of the peroxisome proliferator activated receptor-gamma coactivator-1beta (PGC-1beta) Ala203Pro polymorphism on in vivo metabolism, PGC-1beta expression and fibre type composition in human skeletal muscle. Diabetologia 2007, 50:1615-1620.
10. Kelley D.E., He J., Menshikova E.V., Ritov V.B. Dysfunction of mitochondria in human skeletal muscle in type 2 diabetes. Diabetes 2002, 51:2944-2950.
11. Mootha V.K., Lindgren C.M., Eriksson K.F., Subramanian A., Sihag S., Lehar J., Puigserver P., Carlsson E., Ridderstrale M., Laurila E., Houstis N., Daly M.J., Patterson N., Mesirov J.P., Golub T.R., Tamayo P., Spiegelman B., Lander E.S., Hirschhorn J.N., Altshuler D., Groop L.C. PGC-1alpha-responsive genes involved in oxidative phosphorylation are coordinately downregulated in human diabetes. Nat. Genet. 2003, 34:267-273.
12. Patti M.E., Butte A.J., Crunkhorn S., Cusi K., Berria R., Kashyap S., Miyazaki Y., Kohane I., Costello M., Saccone R., Landaker E.J., Goldfine A.B., Mun E., DeFronzo R., Finlayson J., Kahn C.R., Mandarino L.J. Coordinated reduction of genes of oxidative metabolism in humans with insulin resistance and diabetes: potential role of PGC1 and NRF1. Proc. Natl Acad. Sci. U.S.A. 2003, 100:8466-8471.
13. Poulsen P., Levin K., Beck-Nielsen H., Vaag A. Age-dependent impact of zygosity and birth weight on insulin secretion and insulin action in twins. Diabetologia 2002, 45:1649-1657.
14. Poulsen P., Levin K., Petersen I., Christensen K., Beck-Nielsen H., Vaag A. Heritability of insulin secretion, peripheral and hepatic insulin action, and intracellular glucose partitioning in young and old Danish twins. Diabetes 2005, 54:275-283.
15. Ling C., Poulsen P., Carlsson E., Ridderstrale M., Almgren P., Wojtaszewski J., Beck-Nielsen H., Groop L., Vaag A. Multiple environmental and genetic factors influence skeletal muscle PGC-1alpha and PGC-1beta gene expression in twins. J. Clin. Invest. 2004, 114:1518-1526.
16. Eriksson K.F., Lindgarde F. Impaired glucose tolerance in a middle-aged male urban population: a new approach for identifying high-risk cases. Diabetologia 1990, 33:526-531.
17. Alberti K.G., Zimmet P.Z. Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation. Diabet. Med. 1998, 15:539-553.
18. Brooke M.H., Kaiser K.K. Three "myosin adenosine triphosphatase" systems: the nature of their pH lability and sulfhydryl dependence. J. Histochem. Cytochem. 1970, 18:670-672.
19. Vandenplas S., Wiid I., Grobler-Rabie A., Brebner K., Ricketts M., Wallis G., Bester A., Boyd C., Mathew C. Blot hybridisation analysis of genomic DNA. J. Med. Genet. 1984, 21:164-172.
20. de Bakker P.I., Yelensky R., Pe'er I., Gabriel S.B., Daly M.J., Altshuler D. Efficiency and power in genetic association studies. Nat. Genet. 2005, 37:1217-1223.
21. Gautier L., Cope L., Bolstad B.M., Irizarry R.A. Affy-analysis of Affymetrix GeneChip data at the probe level. Bioinformatics 2004, 20:307-315.
22. Liang K.Y., Zeger S.L. Regression analysis for correlated data. Annu. Rev. Public Health 1993, 14:43-68.
23. Zeger S.L., Liang K.Y. Longitudinal data analysis for discrete and continuous outcomes. Biometrics 1986, 42:121-130.
24. Neale M.C., Cardon L.R. Methodology for Genetic Studies of Twins and Families 1992, Kluwer Academic Publishers, Dordrecht.
25. Purcell S., Cherny S.S., Sham P.C. Genetic power calculator: design of linkage and association genetic mapping studies of complex traits. Bioinformatics 2003, 19:149-150.
26. Petersen K.F., Befroy D., Dufour S., Dziura J., Ariyan C., Rothman D.L., DiPietro L., Cline G.W., Shulman G.I. Mitochondrial dysfunction in the elderly: possible role in insulin resistance. Science 2003, 300:1140-1142.
27. Ptitsyn A., Hulver M., Cefalu W., York D., Smith S.R. Unsupervised clustering of gene expression data points at hypoxia as possible trigger for metabolic syndrome. BMC Genomics 2006, 7:318.
28. Narkar V.A., Downes M., Yu R.T., Embler E., Wang Y.X., Banayo E., Mihaylova M.M., Nelson M.C., Zou Y., Juguilon H., Kang H., Shaw R.J., Evans R.M. AMPK and PPARdelta agonists are exercise mimetics. Cell 2008, 134:405-415.
29. St-Pierre J., Lin J., Krauss S., Tarr P.T., Yang R., Newgard C.B., Spiegelman B.M. Bioenergetic analysis of peroxisome proliferator-activated receptor gamma coactivators 1alpha and 1beta (PGC-1alpha and PGC-1beta) in muscle cells. J. Biol. Chem. 2003, 278:26597-26603.
30. Wu Z., Puigserver P., Andersson U., Zhang C., Adelmant G., Mootha V., Troy A., Cinti S., Lowell B., Scarpulla R.C., Spiegelman B.M. Mechanisms controlling mitochondrial biogenesis and respiration through the thermogenic coactivator PGC-1. Cell 1999, 98:115-124.
31. Jensen C.B., Storgaard H., Madsbad S., Richter E.A., Vaag A.A. Altered skeletal muscle fiber composition and size precede whole-body insulin resistance in young men with low birth weight. J. Clin. Endocrinol. Metab. 2007, 92:1530-1534.
32. Matolin S., Vaverka F., Lunak J., Novak J., Horak V., Krejci P. Histochemical and functional parameters in Nordic combination athletes. Physiol. Res. 1994, 43:243-251.
33. Petersen K.F., Dufour S., Befroy D., Garcia R., Shulman G.I. Impaired mitochondrial activity in the insulin-resistant offspring of patients with type 2 diabetes. N. Engl. J. Med. 2004, 350:664-671.